This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to the government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Centene is now a $100-billion plus enterprise catering healthcare services to more than 24 million members across 50 states. The recent acquisition of WellCare Health leveraged the company’s position as the largest Medicaid managed care organization in the country. The combined entity now has 22 million members. In 2019, the company retained its market-leading position nationwide, serving 1.8 million exchange members across 20 states at the year-end.
Zacks.com featured highlights include: Molina, Dana, DICK???S, Centene and Covenant
by Zacks Equity Research
Zacks.com featured highlights include: Molina, Dana, DICK???S, Centene and Covenant
Centene (CNC) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of 3.76% and 1.99%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
5 Stocks That Brokers Currently Love: Do You?
by Zacks Equity Research
Given their thorough understanding of the stock market, investors should pay heed to broker advice in order to design a winning portfolio.
What Lies Ahead for Centene (CNC) Stock in Q4 Earnings?
by Zacks Equity Research
Centene's (CNC) fourth-quarter earnings are likely to gain traction from growth in revenues and membership strength, partly offset by high operating costs.
Centene (CNC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Centene (CNC) closed at $127.89 in the latest trading session, marking a -0.83% move from the prior day.
Centene (CNC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Centene (CNC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Centene (CNC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Centene (CNC) closed at $125.54, marking a -0.01% move from the previous day.
Will Centene (CNC) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Centene (CNC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights: Centene, Archer Daniels Midland, Spirit Airlines, Pinnacle West and Walmart
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Centene, Archer Daniels Midland, Spirit Airlines, Pinnacle West and Walmart
Recession Risk Hits 7-Year High: 5 Secure Picks
by Swarup Gupta
A Wall Street Journal poll estimates that there is a 25% chance of a recession occurring within the next 12 months.
Has Centene (CNC) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (CNC) Outperforming Other Medical Stocks This Year?
Is Centene (CNC) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina Renews Pact With CVS to Boost PBM Service Platform
by Zacks Equity Research
Molina (MOH) expands deal with CVS Caremark for Pharmacy Benefit Management services.
Is Centene (CNC) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Centene Unit Collaborates With RxAdvance for New PBM Platform
by Zacks Equity Research
Centene's (CNC) Mississippi unit partners RxAdvance for establishing a transformative pharmacy benefit management model.
Healthcare ETFs Sink on JNJ News, ACA Ruling: What???s Ahead?
by Sweta Killa
Healthcare took a hit recently on Johnson & Johnson news and a federal judge ruling. The rough trading also spread into the ETF world.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHMM
WellCare (WCG) Buys Aetna's Medicare Assets to Fuel Growth
by Zacks Equity Research
WellCare's (WCG) purchase of Medicare business of Aetna should lead to long-term growth.
Here's Why Humana (HUM) Stock Looks Attractive Right Now
by Zacks Equity Research
Favorable changes across the industry and Humana's (HUM) strong operating profitability poise it for solid growth.
Centene (CNC) Up 3.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Centene (CNC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Centene (CNC) closed the most recent trading day at $136, moving +0.1% from the previous trading session.
Why UnitedHealth (UNH) is an Attractive Stock to Own Now
by Zacks Equity Research
Medicaid expansion, upward revision in earnings guidance and inherent business strength make UnitedHealth (UNH) an attractive bet.
Should John Hancock Multifactor Mid Cap ETF (JHMM) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for JHMM
Centene (CNC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Centene (CNC) closed at $142.31 in the latest trading session, marking a -0.93% move from the prior day.